Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02331212

Role of Hyaluronic Acid in Causing Cancer Stem Cell Growth in the Bones of Patients With Breast Cancer

Role of Hyaluronic Acid in Cancer Stem Cell Niche

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
Female
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This research trial studies the role of a substance called hyaluronic acid in causing the growth of cancer stem cells in the bones of patients with breast cancer. Cancer stem cells are a type of cancer cells that may cause the cancer to spread to other parts of the body. Studying samples of blood and bone marrow from patients and animal models in the laboratory may help doctors learn more about whether hyaluronic acid affects the growth of cancer in the bones.

Detailed description

PRIMARY OBJECTIVES: I. To evaluate the hypothesis that there are more hyaluronan synthase 2 (HAS2)+ cells in patients with bone metastasis compared to patients with only local disease. SECONDARY OBJECTIVES: I. To evaluate the hypothesis that cells with HAS2+ and cancer stem cell (CSC)+ (cluster of differentiation \[CD\]24-/CD44+/epithelial specific antigen \[ESA\]+) cells will have the most aggressive growth in the bone, using an animal model. OUTLINE: Blood and bone marrow samples are collected and analyzed via flow cytometry and polymerase chain reaction (PCR). Cells are also transplanted into mice and studied.

Conditions

Interventions

TypeNameDescription
OTHERCytology Specimen Collection ProcedureCorrelative studies
OTHERLaboratory Biomarker AnalysisCorrelative studies

Timeline

Start date
2015-03-01
Primary completion
2017-06-01
Completion
2017-06-01
First posted
2015-01-06
Last updated
2018-07-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02331212. Inclusion in this directory is not an endorsement.